Evidence map›Paper›PMID 31857326›Full record

ArticleAJNR. American journal of neuroradiology2020

Number Needed to Treat with Vertebral Augmentation to Save a Life.

J A Hirsch, R V Chandra, N S Carter, D Beall, M Frohbergh, K Ong

Open access · hybridAbstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Article
  4. Review
  5. Real-world rates and risk factors for subsequent treatment with vertebroplasty or balloon kyphoplasty after initial vertebral augmentation: a retrospective cohort study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Article
  6. Review
  7. Review
  8. Review
  9. Vertebral augmentation: an overview.Skeletal radiology · 2023
    Review
  10. Article
  11. Article
  12. Venous injection of a triphasic calcium-based implant in a sheep model of pulmonary embolism demonstrates minimal acute systemic effects.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2022
    Article
  13. Review
  14. Article
  15. Trends in opioid use following balloon kyphoplasty or vertebroplasty for the treatment of vertebral compression fractures.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Cost-effectiveness of balloon kyphoplasty and vertebroplasty versus conservative medical management in the USA.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2020
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

J A HirschFrom the Neuroendovascular Program (J.A.H.), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-9594-8798
R V ChandraFaculty of Medicine (R.V.C., N.S.C.).ORCID 0000-0001-7555-2297
N S CarterFaculty of Medicine (R.V.C., N.S.C.) nicolescarter4@gmail.com.ORCID 0000-0001-9600-8362
D BeallClinical Radiology of Oklahoma (D.B.), Edmond, Oklahoma.ORCID 0000-0001-8340-696X
M FrohberghExponent Inc (M.F., K.O.), Philadelphia, Pennsylvania.ORCID 0000-0002-0167-116X
K OngExponent Inc (M.F., K.O.), Philadelphia, Pennsylvania.ORCID 0000-0003-0893-0993
Exponent (United States) · USHarvard University · USMonash Health · AUNicolet Area Technical College · USOklahoma Library Association · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeEvidence from randomized controlled trials for the efficacy of vertebral augmentation in vertebral compression fractures has been mixed. However, claims-based analyses from national registries or insurance datasets have demonstrated a significant mortality benefit for patients with vertebral compression fractures who receive vertebral augmentation. The purpose of this study was to calculate the number needed to treat to save 1 life at 1 year and up to 5 years after vertebral augmentation. MATERIALS AND

methodsA 10-year sample of the 100% US Medicare data base was used to identify patients with vertebral compression fractures treated with nonsurgical management, balloon kyphoplasty, and vertebroplasty. The number needed to treat was calculated between augmentation and nonsurgical management groups from years 1-5 following a vertebral compression fracture diagnosis, using survival probabilities for each management approach.

resultsThe adjusted number needed to treat to save 1 life for nonsurgical management versus kyphoplasty ranged from 14.8 at year 1 to 11.9 at year 5. The adjusted number needed to treat for nonsurgical management versus vertebroplasty ranged from 22.8 at year 1 to 23.8 at year 5.

conclusionsBoth augmentation modalities conferred a prominent mortality benefit over nonsurgical management in this analysis of the US Medicare registry, with a low number needed to treat. The calculations based on this data base resulted in a low number needed to treat to save 1 life at 1 year and at 5 years.

Indexed as

AgedConservative TreatmentFemaleFractures, CompressionHumansMaleMedicareMiddle AgedSpinal FracturesUnited StatesVertebroplasty

Identifiers

PMID31857326
PMCPMC6975314
OpenAlexW2995913469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.